1 results match your criteria: "all at Creighton University School of Medicine in Omaha[Affiliation]"
Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival.
Fed Pract
August 2019
, and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha.
A National Cancer Database study of on survival outcomes for patients with dedifferentiated liposarcomas found that insurance status, median household income, and treatment facility were associated with differences in median survival and 5- and 10-year survival probabilities.
View Article and Find Full Text PDF